(Q38468490)

3 September 2017

title

Trends in utilization of antiepileptic drugs in Denmark (English)

1 reference

3 September 2017

0 references

6

Hallas J

1 reference

3 September 2017

Tsiropoulos I

1

1 reference

3 September 2017

Gichangi A

2

1 reference

3 September 2017

Andersen M

3

1 reference

3 September 2017

Bjerrum L

4

1 reference

3 September 2017

Gaist D

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

Acta Neurologica Scandinavica

3 September 2017

published in

1 reference

3 September 2017

volume

113

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

405-411

1 reference

The ILAE/IBE/WHO Global Campaign against Epilepsy: Bringing Epilepsy "Out of the Shadows"

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Brain stimulation for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Practice parameter: temporal lobe and localized neocortical resections for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Antiepileptic drug utilization: a Danish prescription database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Individualized drug utilization statistics. Analysing a population's drug use from the perspective of individual users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Use of anticonvulsants for treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Rationale and Evidence for the Use of Oxcarbazepine in Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Extending indications for long-term pharmacotherapy: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Cancer patients' share in a population's use of opioids. A linkage study between a prescription database and the Danish Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

Treatment of depressive disorders in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

The psychiatric comorbidity of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00639.X

10.1111/J.1600-0404.2006.00639.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference